Acute β-Adrenergic Overload Produces Myocyte Damage through Calcium Leakage from the Ryanodine Receptor 2 but Spares Cardiac Stem Cells*

A hyperadrenergic state is a seminal aspect of chronic heart failure. Also, “Takotsubo stress cardiomyopathy,” is associated with increased plasma catecholamine levels. The mechanisms of myocyte damage secondary to excess catecholamine exposure as well as the consequence of this neurohumoral burst on cardiac stem cells (CSCs) are unknown. Cardiomyocytes and CSCs were exposed to high doses of isoproterenol (ISO), in vivo and in vitro. Male Wistar rats received a single injection of ISO (5 mg kg-1) and were sacrificed 1, 3, and 6 days later. In comparison with controls, LV function was impaired in rats 1 day after ISO and started to improve at 3 days. The fraction of dead myocytes peaked 1 day after ISO and decreased thereafter. ISO administration resulted in significant ryanodine receptor 2 (RyR2) hyperphosphorylation and RyR2-calstabin dissociation. JTV519, a RyR2 stabilizer, prevented the ISO-induced death of adult myocytes in vitro. In contrast, CSCs were resistant to the acute neurohumoral overload. Indeed, CSCs expressed a decreased and inverted complement of β1/β2-adrenoreceptors and absence of RyR2, which may explain their survival to ISO insult. Thus, a single injection of ISO causes diffuse myocyte death through Ca2+ leakage secondary to the acutely dysfunctional RyR2. CSCs are resistant to the noxious effects of an acute hyperadrenergic state and through their activation participate in the response to the ISO-induced myocardial injury. The latter could contribute to the ability of the myocardium to rapidly recover from acute hyperadrenergic damage.

[1]  K. Furie,et al.  Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2007, Circulation.

[2]  S. Priori,et al.  Arrhythmogenesis in Catecholaminergic Polymorphic Ventricular Tachycardia: Insights From a RyR2 R4496C Knock-In Mouse Model , 2006 .

[3]  James Coromilas,et al.  Stabilization of cardiac ryanodine receptor prevents intracellular calcium leak and arrhythmias , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Barry J Maron,et al.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interd , 2006, Circulation.

[5]  D. Torella,et al.  Resident human cardiac stem cells: role in cardiac cellular homeostasis and potential for myocardial regeneration , 2006, Nature Clinical Practice Cardiovascular Medicine.

[6]  S. Reiken,et al.  Ryanodine receptor/calcium release channel PKA phosphorylation: a critical mediator of heart failure progression. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[7]  F. Mouquet,et al.  Restoration of Cardiac Progenitor Cells After Myocardial Infarction by Self-Proliferation and Selective Homing of Bone Marrow–Derived Stem Cells , 2005, Circulation research.

[8]  C. Indolfi,et al.  Cardiac stem and progenitor cell biology for regenerative medicine. , 2005, Trends in cardiovascular medicine.

[9]  S. Reiken,et al.  Enhancing calstabin binding to ryanodine receptors improves cardiac and skeletal muscle function in heart failure , 2005 .

[10]  Guy Salama,et al.  Calmodulin kinase II inhibition protects against structural heart disease , 2005, Nature Medicine.

[11]  D. Goldspink,et al.  Catecholamine‐induced apoptosis and necrosis in cardiac and skeletal myocytes of the rat in vivo: the same or separate death pathways? , 2004, Experimental physiology.

[12]  A. Marks,et al.  Novel therapeutic approaches for heart failure by normalizing calcium cycling , 2004, Nature Reviews Drug Discovery.

[13]  Stephan E. Lehnart,et al.  Ca2+/Calmodulin-Dependent Protein Kinase II Phosphorylation Regulates the Cardiac Ryanodine Receptor , 2004, Circulation research.

[14]  Mark A Sussman,et al.  Cardiac Stem Cell and Myocyte Aging, Heart Failure, and Insulin-Like Growth Factor-1 Overexpression , 2004, Circulation research.

[15]  D. Torella,et al.  Adult Cardiac Stem Cells Are Multipotent and Support Myocardial Regeneration , 2003, Cell.

[16]  Clotilde Castaldo,et al.  Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[17]  P. Anversa,et al.  Myocyte death, growth, and regeneration in cardiac hypertrophy and failure. , 2003, Circulation research.

[18]  Guy Vassort,et al.  Protein Kinase A Phosphorylation of the Cardiac Calcium Release Channel (Ryanodine Receptor) in Normal and Failing Hearts , 2003, The Journal of Biological Chemistry.

[19]  P. Anversa,et al.  Myocyte renewal and ventricular remodelling , 2002, Nature.

[20]  P. Anversa,et al.  Evidence that human cardiac myocytes divide after myocardial infarction. , 2001, The New England journal of medicine.

[21]  E. Lakatta,et al.  The β2-Adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes through Gi-Dependent coupling to phosphatidylinositol 3'-kinase , 2000 .

[22]  A. Jaffe,et al.  It's time for a change to a troponin standard. , 2000, Circulation.

[23]  E. Lucchinetti,et al.  β-Adrenergic Receptor Subtypes Differentially Affect Apoptosis in Adult Rat Ventricular Myocytes , 2000 .

[24]  D. Burkhoff,et al.  PKA Phosphorylation Dissociates FKBP12.6 from the Calcium Release Channel (Ryanodine Receptor) Defective Regulation in Failing Hearts , 2000, Cell.

[25]  Catherine Communal,et al.  Opposing Effects of β1- and β2-Adrenergic Receptors on Cardiac Myocyte Apoptosis Role of a Pertussis Toxin–Sensitive G Protein , 1999 .

[26]  W. Gu,et al.  Cardiac Myocyte Terminal Differentiation , 1995 .

[27]  M. Pfeffer,et al.  Progressive ventricular remodeling in response to diffuse isoproterenol-induced myocardial necrosis in rats. , 1994, Circulation research.

[28]  W. R. Taylor,et al.  Autocrine control of wound repair by insulin-like growth factor I in cultured endothelial cells. , 1993, The American journal of physiology.

[29]  J. Cohn,et al.  Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. , 1984, The New England journal of medicine.

[30]  Stephan E Lehnart,et al.  Intracellular calcium release and cardiac disease. , 2005, Annual review of physiology.